The Medicines Company Slashes Hundreds of Jobs in Restructuring Post author:Sam Post published:October 24, 2017 Post category:BioPharma In addition to the layoffs, the company is also looking to divest its Infectious Disease Business. Source: BioSpace You Might Also Like Catabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society September 14, 2017 BIOTRONIK Release: New ICD Lead With Helical Design Now Launched In Europe April 5, 2017 3 Biotechs to Load Up on This Holiday Season November 30, 2017
Catabasis To Present Results From The Open-Label Extension Of The Movedmd Phase II Trial Of Edasalonexent In Duchenne Muscular Dystrophy In A Late Breaking Session Of The World Muscle Society September 14, 2017